APA (7th ed.) Citation

Anwar, H., Winkler, J. K., Haberkorn, U., Hassel, J. C., & Dimitrakopoulou-Strauss, A. (2018). Absolute number of new lesions on 18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab. European journal of nuclear medicine and molecular imaging, 45(3), . https://doi.org/10.1007/s00259-017-3870-6

Chicago Style (17th ed.) Citation

Anwar, Hoda, Julia K. Winkler, Uwe Haberkorn, Jessica C. Hassel, and Antonia Dimitrakopoulou-Strauss. "Absolute Number of New Lesions on 18F-FDG PET/CT Is More Predictive of Clinical Response than SUV Changes in Metastatic Melanoma Patients Receiving Ipilimumab." European Journal of Nuclear Medicine and Molecular Imaging 45, no. 3 (2018). https://doi.org/10.1007/s00259-017-3870-6.

MLA (9th ed.) Citation

Anwar, Hoda, et al. "Absolute Number of New Lesions on 18F-FDG PET/CT Is More Predictive of Clinical Response than SUV Changes in Metastatic Melanoma Patients Receiving Ipilimumab." European Journal of Nuclear Medicine and Molecular Imaging, vol. 45, no. 3, 2018, https://doi.org/10.1007/s00259-017-3870-6.